##gff-version 3
##sequence-region Q8N163 1 923
Q8N163	UniProtKB	Chain	1	923	.	.	.	ID=PRO_0000050813;Note=Cell cycle and apoptosis regulator protein 2	
Q8N163	UniProtKB	Region	610	670	.	.	.	Note=Interaction with MCC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24824780;Dbxref=PMID:24824780	
Q8N163	UniProtKB	Region	704	923	.	.	.	Note=Interaction with NR1D1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23398316;Dbxref=PMID:23398316	
Q8N163	UniProtKB	Coiled coil	829	909	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8N163	UniProtKB	Modified residue	35	35	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231;Dbxref=PMID:19690332,PMID:20068231	
Q8N163	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine%3B by KAT8;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24126058;Dbxref=PMID:24126058	
Q8N163	UniProtKB	Modified residue	123	123	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8N163	UniProtKB	Modified residue	124	124	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8N163	UniProtKB	Modified residue	180	180	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8N163	UniProtKB	Modified residue	215	215	.	.	.	Note=N6-acetyllysine%3B by KAT8;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19608861,ECO:0000269|PubMed:24126058;Dbxref=PMID:19608861,PMID:24126058	
Q8N163	UniProtKB	Modified residue	454	454	.	.	.	Note=Phosphothreonine%3B by ATM%2C ATR and CK2;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:22735644,ECO:0000269|PubMed:24962073;Dbxref=PMID:23186163,PMID:22735644,PMID:24962073	
Q8N163	UniProtKB	Modified residue	484	484	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q8N163	UniProtKB	Modified residue	569	569	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q8N163	UniProtKB	Modified residue	627	627	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q8N163	UniProtKB	Modified residue	675	675	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:17081983,PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163	
Q8N163	UniProtKB	Modified residue	678	678	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:17081983,PMID:18669648,PMID:19690332,PMID:20068231,PMID:21406692,PMID:23186163	
Q8N163	UniProtKB	Modified residue	681	681	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:17081983,PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163	
Q8N163	UniProtKB	Modified residue	687	687	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q8N163	UniProtKB	Modified residue	808	808	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N163	UniProtKB	Modified residue	897	897	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N163	UniProtKB	Cross-link	591	591	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3)%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25406032;Dbxref=PMID:25406032	
Q8N163	UniProtKB	Cross-link	591	591	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
Q8N163	UniProtKB	Alternative sequence	910	923	.	.	.	ID=VSP_017092;Note=In isoform 2. ADSWVEKEEPAPSN->VRWGWTRRQHSSFP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11853319;Dbxref=PMID:11853319	
Q8N163	UniProtKB	Mutagenesis	243	264	.	.	.	Note=Abolishes binding to SIRT1. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18235501;Dbxref=PMID:18235501	
Q8N163	UniProtKB	Mutagenesis	454	454	.	.	.	Note=Significantly reduces association with SIRT1. Decreases sumoylation and the interaction of the sumoylated form with SIRT1. Inhibits CCAR2-PSIA3 interaction. Increases CCAR2-SENP1 interaction. Down-regulation of the signals related with the epithelial-mesenchymal transition of gastric cancer cells. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22735644,ECO:0000269|PubMed:24962073,ECO:0000269|PubMed:25406032;Dbxref=PMID:22735644,PMID:24962073,PMID:25406032	
Q8N163	UniProtKB	Mutagenesis	454	454	.	.	.	Note=Significantly increases association with SIRT1 and induces p53 acetylation and apoptosis. Increases sumoylation and the interaction of the sumoylated form with SIRT1. Promotes CCAR2-PSIA3 interaction. Decreases CCAR2-SENP1 interaction. T->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22735644,ECO:0000269|PubMed:25406032;Dbxref=PMID:22735644,PMID:25406032	
Q8N163	UniProtKB	Mutagenesis	591	591	.	.	.	Note=Loss of sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25406032;Dbxref=PMID:25406032	
Q8N163	UniProtKB	Mutagenesis	667	667	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25406032;Dbxref=PMID:25406032	
Q8N163	UniProtKB	Mutagenesis	839	839	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25406032;Dbxref=PMID:25406032	
Q8N163	UniProtKB	Sequence conflict	47	47	.	.	.	Note=R->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N163	UniProtKB	Sequence conflict	47	47	.	.	.	Note=R->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N163	UniProtKB	Sequence conflict	850	850	.	.	.	Note=T->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N163	UniProtKB	Sequence conflict	908	908	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N163	UniProtKB	Sequence conflict	908	908	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
